CN2 (Niacin Extended-Release 750 mg)

Pill with imprint CN2 is Orange, Capsule-shape and has been identified as Niacin Extended-Release 750 mg. It is supplied by Jubilant Cadista Pharmaceuticals Inc.

Niacin is used in the treatment of high cholesterol; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia; niacin deficiency; hyperlipoproteinemia type v, elevated chylomicrons vldl and belongs to the drug classes miscellaneous antihyperlipidemic agents, vitamins. Risk cannot be ruled out during pregnancy. Niacin 750 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CN2

Niacin Extended-Release

Imprint: CN2
Strength: 750 mg
Color: Orange
Size: 19.00 mm
Shape: Capsule-shape
Availability: Rx and/or OTC
Drug Class: Miscellaneous antihyperlipidemic agents, Vitamins
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: Jubilant Cadista Pharmaceuticals Inc.
Manufacturer: Jubilant Generics Limited
National Drug Code (NDC): 59746-0381
Inactive Ingredients: ferric oxide red, ferric oxide yellow, FD&C Yellow No. 6, hypromelloses, povidone, polyethylene glycol 400, stearic acid, titanium dioxide
Note: Inactive ingredients may vary.